People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Islet Sciences, Inc | — | Biotechnology | Series A | $8.5M | $80.3M | 2013 |
| Vogenx, Inc. | — | Pharmaceuticals | Pre-Seed | $750K | $1.5M | 2025 |
WILLIAM WILKISON at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside WILLIAM WILKISON on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Green | 2 | 9 |
| Michael Luther | 1 | 4 |
| Tim Boris | 1 | 3 |
| JOHN STEEL | 1 | 2 |
| ERIC BARNETT | 1 | 2 |
| RICHARD EGAN | 1 | 2 |
| GEORGE TODARO | 1 | 1 |
| Pete Pieraccini | 1 | 1 |
| Steven Delmar | 1 | 1 |
| Richard Gorman | 1 | 1 |
| JONATHAN LAKEY | 1 | 1 |
| JOEL PERLIN | 1 | 1 |
| JERRY NADLER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.